What is the pathophysiology of Respiratory Syncytial Virus (RSV) bronchiolitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of RSV Bronchiolitis

RSV bronchiolitis is characterized by acute inflammation, edema and necrosis of epithelial cells lining the small airways, increased mucus production, and bronchospasm, leading to bronchiolar obstruction through a combination of epithelial destruction, inflammatory cell infiltration, and debris accumulation. 1

Primary Pathologic Mechanisms

Epithelial Cell Damage and Necrosis

  • Circumferential infection of small bronchiole epithelium occurs, with basal cells characteristically spared from infection 2
  • Both type 1 and type 2 alveolar pneumocytes become infected during RSV bronchiolitis 2
  • Necrosis of respiratory epithelium is a hallmark feature, with columnar cell cytopathology in the bronchioles directly impacting the development of bronchiolar obstruction 3, 4
  • Epithelial cell debris contributes significantly to airway obstruction 2

Inflammatory Response

  • Inflammatory infiltrates center on bronchial and pulmonary arterioles, consisting primarily of CD69+ monocytes, CD3+ double-negative T cells, CD8+ T cells, and neutrophils 2
  • Submucosal cellular infiltration with lymphocytic infiltration occurs throughout the small airways 3, 5
  • Most inflammatory cells concentrate submuscular to the airway, but many cells traverse the smooth muscle into the airway epithelium and lumen 2
  • Neutrophil distribution is predominantly between arterioles and airways, while mononuclear cell distribution occurs in both airways and lung parenchyma 2

Airway Obstruction

  • Airway obstruction results from epithelial and inflammatory cell debris mixed with fibrin, mucus, and edema 2
  • Dense plugs of debris form in the bronchioles, causing subsequent bronchiolar obstruction 3
  • Excessive mucus production contributes to the obstructive process 1, 3
  • Compression from hyperplastic lymphoid follicles compounds the obstruction 2

Physiologic Consequences

Respiratory Mechanics

  • Functional residual capacity (FRC) increases due to air trapping 5
  • Dynamic compliance falls as a result of small airway obstruction 5
  • Bronchospasm contributes to airway narrowing, though failure to respond to bronchodilators suggests muscle spasm plays a relatively minor role compared to inflammatory obstruction 1, 5

Immunologic Mechanisms

  • IgE-mediated reactions and release of inflammatory mediators may exacerbate acute obstruction 3
  • IgE antibodies to RSV and leukotriene C4 are found more frequently in respiratory secretions of infants who wheeze during and after bronchiolitis 5
  • These immunologic responses may contribute to chronic obstructive pulmonary dysfunction following acute infection 3

Clinical Manifestations of Pathophysiology

The pathophysiologic changes manifest clinically as tachypnea, wheezing, crackles, use of accessory muscles, and nasal flaring 1. The inflammatory obstruction and epithelial damage explain why affected infants become increasingly dyspneic and hypoxic for 3-4 days before spontaneous improvement occurs 5. The predominance of inflammatory debris over bronchospasm explains the limited efficacy of bronchodilator therapy in this condition 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The histopathology of fatal untreated human respiratory syncytial virus infection.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2007

Research

Pathogenesis and treatment of bronchiolitis.

Clinical pharmacy, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.